Clinical Validation of a Video-based Epilepsy Examination Service

A Study of Brivaracetam in Subjects With Partial Onset Seizures

NCT00175929 ·Status: COMPLETED ·Phase: PHASE2

A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.

NCT00175890 ·Status: COMPLETED ·Phase: PHASE3

Effect of Levetiracetam on Brain Excitability

NCT00006191 ·Status: COMPLETED

Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children

NCT01521130 ·Status: COMPLETED ·Phase: PHASE1

The GABAergic Inhibitory System in Drug Resistant Epilepsy

NCT06789497 ·Status: COMPLETED ·Phase: NA

Lamotrigine Versus Levetiracetam in the Initial Monotherapy of Epilepsy

NCT00242606 ·Status: COMPLETED ·Phase: PHASE3

A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.

NCT00175825 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: Brivaracetam

NCT00736931 ·Status: COMPLETED ·Phase: PHASE1

Neurodevelopmental Impact of Epilepsy on Autonomic Function in Dravet Syndrome

NCT05472389 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Intravenous Brivaracetam in Subjects >= 1 Month to < 16 Years of Age With Epilepsy

NCT03405714 ·Status: COMPLETED ·Phase: PHASE2

Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy

NCT00454935 ·Status: UNKNOWN

Cognitive Effects of Vinpocetine in Healthy Adults and Patients With Epilepsy

NCT02011971 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2

An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam

NCT00761774 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury and Cognitive Impairment

NCT00171795 ·Status: COMPLETED ·Phase: PHASE3

A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures

NCT00105040 ·Status: COMPLETED ·Phase: PHASE2

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

NCT00490035 ·Status: COMPLETED ·Phase: PHASE3

Does Short-Term Anti-Seizure Prophylaxis After Traumatic Brain Injury Decrease Seizure Rates?

NCT03054285 ·Status: UNKNOWN ·Phase: PHASE4

Levetiracetam Treatment of Children With Subclinical Sleep-Activated Epileptiform Activity (SSEA)

NCT00393614 ·Status: UNKNOWN ·Phase: PHASE4

Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults

NCT00357669 ·Status: COMPLETED ·Phase: PHASE3

A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)

NCT00247364 ·Status: COMPLETED ·Phase: PHASE2

Brivaracetam as add-on Treatment in Adolescents and Adults Suffering From Epilepsy

NCT00504881 ·Status: COMPLETED ·Phase: PHASE3

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

NCT01484977 ·Status: COMPLETED ·Phase: PHASE3

Levetiracetam for Alzheimer's Disease Neuropsychiatric Symptoms Related to Epilepsy Trial (LAPSE)

NCT04004702 ·Status: UNKNOWN ·Phase: PHASE2

Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures

NCT00152516 ·Status: COMPLETED ·Phase: PHASE3

Cognitive and Behavioral Effects of Lacosamide

NCT01175954 ·Status: COMPLETED ·Phase: PHASE4